Futility: Clinical decisions at the end-of-life in women with ovarian cancer

Gynecologic Oncology

Volumn 97, Issue 2, 2005, Pages 638-644

  Von Gruenigen, Vivian E ^a,c   Daly, Barbara J ^b,c  

^a Department of Obstetrics and Gynecology   (United States)

^b Clin Ethics and School of Nursing   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

End of life; Futility; Ovarian cancer

Indexed keywords

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; DECISION MAKING; DOCTOR PATIENT RELATION; FEMALE; GOOD CLINICAL PRACTICE; HEALTH CARE QUALITY; HUMAN; LEGAL ASPECT; MEDLINE; MORALITY; OVARY CARCINOMA; PARENTERAL NUTRITION; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL TIME; TREATMENT REFUSAL;

EID: 18144406881     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.01.031     Document Type: Review

References (61)

1. R.D. Truog, A.S. Brett, and J. Frader The problem with futility N. Engl. J. Med. 12 1992 1560 1563
2. Ethics Committee of the Society of Critical Care Medicine Consensus statement of the Society of Critical Care Medicine's Ethics Committee regarding futile and other possibly inadvisable treatments Crit. Care Med. 25 1997 887 891
3. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Deciding to forego life-sustaining treatment. Washington, DC: US Government Printing Office; 1983 0-425-748.
4. R.F. Weir Abating treatment with critically ill patients 1989 Oxford Univ. Press New York
5. Institute of Medicine, Committee on Care at the End of Life Approaching death: improving care at the end of life 1997 National Academy Press Washington, DC
6. L.J. Schneiderman, N.S. Jecker, and A.R. Jonsen Medical futility; its meaning and ethical implications Ann. Int. Med. 112 1990 949 954
7. S.J. Youngner Who defines futility? JAMA 260 1988 2094 2095
8. T.L. Beauchamp, and J.F. Childress Principles of medical ethics 3rd ed. 1989 Oxford Univ. Press New York
9. H.T. Engelhardt The foundations of bioethics 1986 Oxford Univ. Press New York
10. R.M. Veatch A theory of medical ethics 1981 Basic Books New York
11. Bay Area Network of Ethics Committees Nonbeneficial or futile medical treatment: conflict resolution guidelines for the San Francisco Bay Area West. J. Med. 170 1990 287 290
12. A. Halevy, and B.A. Brody A multi-institutional collaborative policy on medical futility JAMA 276 1996 571 574
13. J.M. Luce Physicians do not have a responsibility to provide futile or unreasonable care if a patient or family insists Crit. Care Med. 23 1995 760 766
14. T. Tomlinson, A.J. Michalski, R.D. Penta, and M. Kuuppelomaki Futile care in oncology: when to stop trying Lancet Oncol. 2 2001 759 764
15. C. Daugherty, M.J. Ratain, E. Grochowski, C. Stocking, E. Kodish, and R. Mick Perceptions of cancer patients and their physicians involved in phase I trials J. Clin. Oncol. 13 1995 1062 1072
16. S. Horng, E.J. Emanuel, B. Wilfond, J. Rackoff, K. Martz, and C. Grady Descriptions of benefits and risks in consent forms for phase I oncology trials N. Engl. J. Med. 347 2002 2134 2140
17. H. Hinkka, E. Kosunen, R. Metsanoja, U.-K. Lammi, and P. Kellokumpu-Lehtinen Factors affecting physicians' decisions to forgo life-sustaining treatments in terminal care J. Med. Ethics 28 2002 109 114
18. E.W. Mebane, R.F. Oman, L.T. Krooman, and M.K. Goldstein The influence of physician race, age, and gender on physician attitudes toward advance care directives and preferences for end-of-life decision-making J. Am. Geriatr. Soc. 47 1999 579 591
19. N.A. Christakis, and D.A. Asch Biases in how physicians choose to withdraw life support Lancet 342 1993 642 646
20. J.W. Swanson, and S. Van McCrary Doing all they can: physicians who deny medical futility J. Law Med. Ethics 22 4 1994 318 326
21. N.A. Christakis, and D.A. Asch Physician characteristics associated with decisions to withdraw life support Am. J. Public Health 85 1995 367 372
22. D.J. Cook, G.H. Guyatt, R. Jaeschke, J. Reeve, A. Spanier, and D. King Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill JAMA 273 1995 703 708
23. M.F. Johnson, and A.M. Kramer Physicians' responses to clinical scenarios involving life-threatening illness vary by patient age J. Clin. Ethics 11 2000 323 327
24. R.M. Wachter, J.M. Luce, N. Hearst, and B. Lo Decisions about resuscitation: inequities among patients with different diseases but similar prognoses Ann. Int. Med. 111 1989 525 532
25. E.J. Emanuel, Y. Young-Xu, N.G. Levinsky, G. Gazelle, O. Saynina, and A.S. Ash Chemotherapy use among medicare beneficiaries at the end of life Ann. Intern. Med. 138 2003 639 643
26. V.E. von Gruenigen, H.E. Frasure, A.M. Reidy, and K.M. Gil Clinical disease course during the last year in ovarian cancer Gynecol. Oncol. 90 3 2003 619 624
27. J.L. Dalrymple, C. Levenback, J.K. Wolf, D.C. Bodurka, M. Garcia, and D.M. Gershenson Trends among gynecologic oncology inpatient deaths: is end-of-life care improving? Gynecol. Oncol. 85 2002 356 361
28. J.H. Rose, E.E. O'Toole, N.V. Dawson, D. Gurley, C. Thomas, and M.B. Hamel Perspectives, preferences, care practices, and outcomes among older and middle-aged patients with late-stage cancer J. Clin. Oncol. 22 24 2004 4907 4917
29. E.J. Gordon, and C.K. Daugherty 'Hitting you over the head': oncologists' disclosure of prognosis in advanced cancer patients Bioethics 17 2 2003 142 168
30. W.F. Baile, R. Lenzi, P.A. Parker, R. Buckman, and L. Cohen 'Oncologists' attitudes toward and practices in giving bad news: an exploratory study J. Clin. Oncol. 20 2002 2189 2196
31. A. Jemal, R.C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, and E. Ward Cancer statistics 2004 CA Cancer J. Clin. 54 2004 8 29
32. L.M. Ramondetta, G. Tortolero-Luna, D.C. Bodurka, D. Sills, K. Basen-Engquist, and J. Gano Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study Int. J. Gynecol. Cancer 14 4 2004 580 588
33. J.A. Roberts, D. Brown, T. Elkins, and D.B. Larson Factors influencing views of patients with gynecologic cancer about end-of-life decisions Am. J. Obstet. Gynecol. 176 1997 166 172
34. E. Chow, T. Harth, G. Hruby, J. Finkelstein, J. Wu, and C. Danjoux How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review Clin. Oncol. 13 2001 209 218
35. A. Vigano, M. Dorgan, E. Bruera, and M.E. Suarez-Almazor The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer Cancer 86 1999 170 176
36. J.C. Weeks, E.F. Cook, S.J. O'Day, L.M. Peterson, N. Wenger, and D. Reding 'Relationship between cancer patients' predictions of prognosis and their treatment preferences JAMA 279 21 1998 1709 1714
37. R.T. Penson, F. Dignan, M.V. Seiden, H. Lee, C.J. Gallagher, and U.A. Matulonis Attitudes to chemotherapy in patients with ovarian cancer Gynecol. Oncol. 94 2004 427 435
38. C. Doyle, M. Crump, M. Pintilie, and A.M. Oza Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer J. Clin. Oncol. 19 2001 1266 1274
39. R. Buckman How to break bad news: a guide for health care professionals 1992 Johns Hopkins Press Baltimore
40. Cancer care during the last phase of life J. Clin. Oncol. 16 1998 1986 1996
41. Clinical practice guidelines for the treatment of unresectable nonsmall-cell lung cancer J. Clin. Oncol. 15 8 1997 2996 3018
42. J.P. Durand, P. Vinant-Binam, J. Alexandre, L. Zivkovic, Y. Guillard, and S. Dispa Decision-making in incurable cancers: a retrospective analysis of 150 patients entered into the CTRL algorithm of Cochin Presented at the American Society of Clinical Oncology Annual Meeting, New Orleans, LA, June 5-8 2004
43. G.I. Benrubi The gynecologic oncologist and futile therapy in a managed care setting Curr. Women's Health Rep. 2 3 2002 159 162
44. C.P. Escalante, C.G. Martin, L.S. Elting, and E.B. Rubenstein Medical futility and appropriate medical care in patients whose death is thought to be imminent Support. Care Cancer 5 1997 274 280
45. S.C. Rubin Intestinal obstruction in advanced ovarian cancer: what does the patient want? Gynecol. Oncol. 75 1999 311 312
46. D. Cheng, Y.M. Chan, T.Y. Ng, A.N. Cheung, H.Y. Ngan, and L.C. Wong Mitomycin chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to gynecological cancer Acta Obstet. Gynecol. Scand. 78 1999 443 446
47. D.S. Chi, J.B. Liao, L.F. Leon, E.S. Venkatraman, M.L. Hensley, and D. Bhaskaran Identification of prognostic factors in advanced epithelial ovarian carcinoma Gynecol. Oncol. 82 2001 532 537
48. M.A. Morgan, T.D. Iyengar, B.E. Napiorkowski, S.C. Rubin, and J.J. Mikuta The clinical course of deep vein thrombosis in patients with gynecologic cancer Gynecol. Oncol. 84 2002 67 71
49. L.E. Puls, T. Duniho, J.E. Hunter, R. Kryscio, D. Blackhurst, and H. Gallion The prognostic implication of ascites in advanced-stage ovarian cancer Gynecol. Oncol. 61 1996 109 112
50. D. Brown, J.A. Roberts, T.E. Elkins, D. Larson, and M. Hopkins Hard choices: the gynecologic cancer patient's end-of-life preferences Gynecol. Oncol. 55 1994 355 362
51. K.A. Donovan, P.G. Greene, J.L. Shuster, E.E. Partridge, and D.C. Tucker Treatment preferences in recurrent ovarian cancer Gynecol. Oncol. 86 2002 200 211
52. P.J. Allison, C. Guichard, K. Fung, and L. Gilain Dispositional optimism predicts survival status 1 year after diagnosis in head and neck cancer patients J. Clin. Oncol. 21 2003 543 548
53. M. Gattellari, K.J. Voigt, P.N. Butow, and M.H.N. Tattersall When the treatment goal is not cure: are cancer patients equipped to make informed decisions? J. Clin. Oncol. 20 2002 503 513
54. R.G. Hagerty, P.N. Butow, P.A. Ellis, E.A. Lobb, S. Pendlebury, and N. Leighl Cancer patient preferences for communication of prognosis in the metastatic setting J. Clin. Oncol. 22 2004 1721 1730
55. D.B. Hinshaw, T. Pawlik, A.C. Mosenthal, J.M. Civetta, and J. Hallenbeck When do we stop, and how do we do it? Medical futility and withdrawal of care J. Am. Coll. Surg. 196 4 2003 621 651
56. M.D. Wenrish, J.R. Curtis, S.E. Shannon, J.D. Carline, D.M. Ambrozy, and P.G. Ramsey Communicating with dying patients within the spectrum of medical care from terminal diagnosis to death Arch. Intern. Med. 161 6 2001 868 874
57. B. Ambuel Conducting a family conference. Principles and practice of supportive oncology updates 2000 Lippincott Williams and Wilkins New York
58. J. Cain, L. Stacy, K. Jusenius, and D. Figge The quality of dying: financial, psychological, and ethical dilemmas Obstet. Gynecol. 76 1990 149 152
59. P.R. Harnett, and T.J. Moynihan The art of oncology: when the tumor is not the target. "But doctor, what have I got to lose...?" J. Clin. Oncol. 19 13 2001 3294 3296
60. V. von Gruenigen, L. White, M. Hopkins, M. Kirven, A. Showalter, and E.J. Jenison The comparison of complementary and alternative medicine between gynecologic and gynecologic oncology patients Int. J. Gynecol. Oncol. 11 2001 205 209
61. E. Rothchild Family dynamics in end-of-life treatment decisions Gen. Hosp. Psychiat. 16 1994 251 258